Abstract
Arterial thrombosis underlies cardiovascular diseases including myocardial infarction and ischaemic stroke. New insight in the pathophysiology of atherosclerosis and thrombosis stimulated the development of targeted antithrombotic medication. In this chapter, we discuss thrombus forming mechanisms, and indications for targeted antithrombotic medication in patients with atherothrombotic conditions and thromboembolic stroke.
| Original language | English |
|---|---|
| Title of host publication | Hoffbrand's Postgraduate Haematology |
| Editors | Adam J Mead, Michael A Laffan, Graham P Collins, Deborah Hay, A Victor Hoffbrand |
| Publisher | Wiley |
| Chapter | 50 |
| Pages | 932-946 |
| Number of pages | 15 |
| Edition | 8 |
| ISBN (Electronic) | 9781119706687 |
| ISBN (Print) | 9781119706618 |
| DOIs | |
| Publication status | Published - 1 Jan 2025 |
Keywords
- anticoagulants
- antiplatelet therapy
- antithrombotic
- Arterial thrombosis
- ischemic stroke
- myocardial infarction
- platelets-atherosclerosis